Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™<i>plus</i>

El-Toukhy, Tarek; Chandakas, S.; Grigoriadis, Themos; Hill, N. C. W.; Erian, J.

doi:10.1080/01443610400008024

Cited by 12 publications

(7 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The success rate of the present study (88.5%) was comparable with other studies which have used this method for destroying the endometrium [14][15][16][17][18][19][20][21][22][23][24][25] (Table 3). Also, our results indicated a higher rate of success in comparison to to other methods for the ablation of the endometrium [9,10,26,29,30].…”

Section: Discussionsupporting

confidence: 79%

Thermal Balloon Ablation for Dysfunctional Uterine Bleeding among Iranian Patients

Ashrafganjoei¹,

Bouzari²,

Farzaneh³

et al. 2016

J Res Med Den Sci

View full text Add to dashboard Cite

Objective: dysfunctional uterine bleeding is a common gynecological condition which affects about 20-30% of premenopausal women. When medical treatments fail to provide adequate relief, surgical interventions, including hysterectomy or destruction of the endometrium, might be considered. The aim of the present study was to determine the menstrual outcomes and the satisfaction level, after thermal balloon endometrial ablation to treat this condition among Iranian patients. Design classification: A single-arm prospective study. Setting: University teaching hospital. patients:52 patients with dysfunctional uterine bleeding. Intervention: Patients underwent endometrial ablation using Cavaterm plus and were fallowed up for 12 months, Post operatively. Measurements: The pictorial blood loss assessment chart score of menstrual cycle, number of days in the cycle, degree of dysmenorrhea, satisfaction from treatment and any complication of treatment were assessed. Main results: Eighty-eight percent of patients responded to treatment; the mean number of days of bleeding per month decreased from a mean of 13.6 to 4days (p<0.001) and the mean amount of bleeding decreased from 535.4 to 38.6 in pictorial blood loss assessment chart (p<0/001). Also 45% of patients became amenorrheic after one year fallow up and 88% were satisfied with their treatment. Conclusions: Thermal balloon endometrial ablation among our patients showed a similar outcome to previous reported studies. It seems that this method represents an excellent alternative to hysterectomy, with high rate of success, a very low complications rate and high patients satisfaction.

show abstract

Section: Discussionsupporting

confidence: 79%

Thermal Balloon Ablation for Dysfunctional Uterine Bleeding among Iranian Patients

Ashrafganjoei¹,

Bouzari²,

Farzaneh³

et al. 2016

J Res Med Den Sci

View full text Add to dashboard Cite

show abstract

“…As we had no information about follicle‐stimulating hormone levels, we did not know whether the possible amenorrhoea was due to the procedure or menopause. In addition, the device used was unknown in most cases, but according to previous studies, there is no evidence of the superiority of one device over another (6), (9), (17).…”

Section: Discussionmentioning

confidence: 99%

Endometrial thermal balloon ablation has a beneficial long‐term effect on menorrhagia

Ahonkallio

Martikainen

Santala

2008

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

show abstract

“…The largest study to date reported on 220 patients treated with the Cavaterm Plus device, with follow-up for an average of 19 months. 75 The satisfaction rate at the end of the follow-up interval was 83%. Another study of 50 patients followed for an average of 14 months (range, 6 to 24 mo) reported a short-term success rate of 96%, with 68% of patients developing amenorrhea, 24% with spotting, 4% eumenorrhea, and 4% failures.…”

Section: Cavatermmentioning

confidence: 98%

Endometrial Ablation: Where Have We Been? Where Are We Going?

Munro

2006

Clinical Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

Endometrial ablation (EA) is targeted destruction of the endothelial surface of the uterine cavity. The procedure was originally designed as a less invasive alternative to hysterectomy for the symptom of heavy menstrual bleeding unrelated to structural pathology of the uterus, that was not responsive to medical therapy. More recently it has become apparent that the procedure can be performed in the presence of submucous leiomyomas, providing they meet a number of size and location criteria. The first EA serie as published in Germany in the 1930s, but the procedure did not attract much attention until the latter part of the 20th century. Currently, EA can be performed under endoscopic direction with the neodymium:yttrium alumnum garnet laser, with a radiofrequency resectoscope, or with an expanding array of nonresectoscopic EA systems. It is apparent that most but not all of the complications associated with resectoscopic endometrial ablation are eliminated with nonresectoscopic endometrial ablation, but serious morbidity has been reported with all of the newer systems to date. Success and patient satisfaction seem to be enduring in the majority of well-selected patients treated in clinical trials, but repeat surgery, usually hysterectomy, is performed in 25% to 40% by 5 years after surgery. Increased efficiencies should be realized if the procedure could be moved to an office setting.

show abstract

Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™plus

Cited by 12 publications

References 34 publications

Thermal Balloon Ablation for Dysfunctional Uterine Bleeding among Iranian Patients

Thermal Balloon Ablation for Dysfunctional Uterine Bleeding among Iranian Patients

Endometrial thermal balloon ablation has a beneficial long‐term effect on menorrhagia

Endometrial Ablation: Where Have We Been? Where Are We Going?

Contact Info

Product

Resources

About